TerminatedPhase 2NCT01215565

Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma

Studying Fibrolamellar hepatocellular carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Sandrine Faivre, Professor
Assistance Publique Hopitaux de Paris
Intervention
Sutent(drug)
Enrollment
4 target
Eligibility
18 years · All sexes
Timeline
2009 – 2012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01215565 on ClinicalTrials.gov

Other trials for Fibrolamellar hepatocellular carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Fibrolamellar hepatocellular carcinoma →

← Back to all trials